Cancer Care - Common Symptoms in Cancer Patients Flashcards
Pain
Nociceptive Pain
Neuropathic Pain
Causes of Pain in Cancer Patients
Pain Assessment
- ) Nociceptive Pain - direct activation of nociceptors in the peripheral somatosensory system
- somatic: received from skin/bone/muscle, the sensation is a sharp, aching, or throbbing pain
- visceral: received from internal structures such as the GI tract, the sensation is crampy - ) Neuropathic Pain - occurs with an abnormally functioning somatosensory nervous system
- can be due to lesions: ischaemia, compression, infiltration, metabolic injury, transaction of a nerve
- or can be due to dysfunction of the nervous system, abnormal signalling magnifies response to a stimulus
- sensation: burning, tingling, shooting, stabbing, numbness, electric-like sensation - ) Causes of Pain in Cancer Patients
- direct tumour involvement: bone or nerve infiltration
- cancer therapy: post-surgical pain, post-chemo pain (e.g. peripheral neuropathy), post-radiotherapy pain
- not related to cancer or cancer therapy - ) Pain Assessment - impact of the pain, concerns about pain treatment, subjective scale:
- 0 = no pain
- 1-3 = mild pain (little interference with ADLs)
- 4-6 = moderate pain (interferes significantly w/ ADLs)
- 7-10 = severe pain (disabling; cannot perform ADLs)
Step 1 of the WHO Analgesic Ladder
(Simple Analgesics)
Paracetamol
NSAIDs
Adjuvants
- ) Paracetamol - never really given on its own, often used as an adjunct for NSAIDs and opioids
- unknown mechanism of action
- maximum dose is 4g per day (2x500mg QDS)
- risk of overdose/hepatotoxicity but needs 20-30 pills - ) NSAIDs - inhibits COX enzymes –> ↓production of prostaglandins –> ↓inflammation
- often the first line as a simple analgesic
- examples: ibuprofen, naproxen, aspirin, diclofenac
- side effects: renal impairment, N+V, gastric ulcers or bleeding (if regular, should co-prescribe w/ a PPI)
- COX-2 selective NSAIDs (celecoxib, etoricoxib) have reduced GI side effects but have increased CVS risk - ) Adjuvants - non-analgesics used w/ analgesics to help reduce pain, used in all stages (1, 2, and 3)
- often used for neuropathic pain: amitriptyline (TCA) gabapentin and pregabalin (anticonvulsants)
- amitriptyline is contraindicated in arrhythmias and post-MI (during the recovery period)
- steroids: potentiates analgesia, good for pain caused by compression of nerves or spinal cord or ICP
- dexamethasone: specifically good for liver mets
- other adjuvants: anxiolytics, phenothiazines, amphetamines, topical local anaesthetics
Opioids
Weak Opioids
Strong Opioids
Side Effects of Opioids
Special Considerations when Prescribing
- ) Weak Opiates - step 2 of the WHO pain ladder
- codeine, co-codamol, dihydrocodeine, tramadol
- can be prescribed with a laxative or anti-emetic
- opioids are often poor for neuropathic pain, consider early referral to a specialist for neuropathic pain
- tramadol is a serotonin inducing drug so can lead to serotonin syndrome when used with other serotonin based drugs e.g. SSRIs - ) Strong Opiates - step 3 of the WHO pain ladder
- morphine, diamorphine, oxycodone, fentanyl (TD only)
- should stop all weak opioids if on strong opioids
- mild-mod renal impairment (eGFR 10-50): oxycodone is used as it has a quicker onset of action however can still worsen renal failure
- severe renal impairment (eGFR <10): fentanyl (SL fentanyl can be used in the acute pain setting)
- should be co-prescribed with a laxative, can co-prescribe an antiemetic (if new to taking the opioid) - ) Side Effects
- constipation: ↓in intestinal peristalsis and secretions, should always co-prescribe a laxative if regular
- N+V: often transient on initiation, should co-prescribe an anti-emetic on first initiation of an opioid
- drowsiness/sedation: transient for a few days on initiation, shouldn’t be persistent, advised not to drive on first 5 days or after an increase in dose
- dry mouth: have cold drinks, avoid sugary drinks
- opioid toxicity: resp depression, drowsiness, N+V, confusion, hallucinations, pinpoint pupils, jerking, treat with IV naloxone - ) Special Considerations
- renal impairment: use lower doses than normal, stop routine dosing if urine output is minimal or none
- liver failure: reduce dose or increase dosing interval
- metabolism is often not affected by liver metastases
Morphine Prescribing
General Priniciples Regular Doses PRN Doses Other Drugs/Routes Controlled Drug Prescription
- ) General Principles
- total daily doses (TDD): sum of the number of regular doses and the number of PRN doses over 24hrs
- round down when calculating PRN dose - ) Regular Doses - zomorph (SR morphine sulphate)
- always taken 2x a day (BD), 12 hours apart
- SR dose = TDD/2, zomorph only comes in capsules of 10, 30, 60, 100, 200mg, need MST tablets for more flexible doses (5, 10, 15, 30, 60, 100, 200mg)
- all patients on regular (SR) opioids should have IR opioid (oramorph) for breakthrough pain - ) PRN Doses - oramorph (IR morphine sulphate)
- PRN dose = TDD/6, generally round down
- can request another PRN dose after just 1 hour
- consider increasing the routine doses if the patient is using the PRN oramorph 3+ more times a day
- oramorph comes in liquid form and is 10mg/5ml
- bottles of oramorph come in 100, 300, 500ml
- oramorph is also used as PRN in TD fentanyl
- SC morphine is used as PRN for syringe drivers - ) Other Drugs/Routes
- syringe drivers: are used when PO is not feasible, they deliver SC morphine over 24hrs (not BD)
- PO morphine (2):(1) SC morphine
- PO codeine (10):(1) PO morphine
- TD fentanyl –> PO morphine: the smallest patch is 12mcg/hr which equates to 45mg of morphine in 24hrs - ) Controlled Drug Prescription - supply of 2 weeks of opioids on discharge until the GP reviews
- instructions for patient: take morphine SR (zomorph) 60mg BD for 14 days, take morphine IR (oramorph) 10mg PRN up to 1 hourly for breakthrough pain
- instructions for pharmacist: supply 28 (twenty-eight) morphine SR (zomorph) 60mg capsules, supply 1 300ml bottle of morphine IR (oramorph)
- assume oramorph is taken BD for 14 days
Nausea and Vomiting
Control of Nausea and Vomiting
Causes of Nausea and Vomiting
Chemotherapy Induced Nausea and Vomiting
- ) Control of Nausea and Vomiting
- vomiting centre: receptors (H1, 5HT2, NK1, ACh) triggered by the CTZ, CN VIII nucleus, higher and autonomic centres
- CTZ: receptors (D2, 5HT3, NK1), triggered by toxins in blood and the CN VIII nucleus
- vestibulocochlear nucleus: receptors (H1, ACh) - ) Causes of Nausea and Vomiting
- gastric stasis: opioids, ascites, hepatomegaly, post-op
- chemical/metabolic: due to toxins or electrolyte disturbances e.g. sepsis, renal/liver failure, ↓Na, ↑Ca
- bowel obstruction: mechanical or functional
- raised ICP/intracerebral: affects CN VIII nucleus
- movement disorders: e.g. vertigo, ataxia
- constipation, post-op, CINV, anxiety - ) Chemotherapy-Induced Nausea and Vomiting
- risk factors: <50yrs, female, past hx of N+V, specific chemo agents, (smoking is a protective factor)
- Mx: ondansetron (5HT3), aprepitant (NK1) and dexamethasone, metoclopramide (often backup)
Anti-Emetics
Metoclopramide Haloperidol Cyclizine Ondansetron Levomepromazine Dexamethasone
- ) Metoclopramide - D2 (++), 5HT3 (+), PO/SC/IV
- prokinetic: increases gastric emptying by ↑tone at LOS and ↓tone at pyloric sphincter
- usage: gastric stasis, partial/functional obstruction, constipation (alongside laxatives) and chemical N+V
- dose: PO/SC 10mg TDS + PRN
- contraindicated in Parkinson’s due to EPSE - ) Haloperidol - D2 (+++), PO/SC/IM
- best used to treat chemically/metabolically induced vomiting as it acts on D2 receptors in the CTZ (toxins)
- dose: 0.5-1.5mg nocte + PRN
- contraindicated in Parkinson’s due to EPSE
- D2 antagonists: prochlorperazine, domperidone (safe in Parkinson’s as it doesn’t cross the BBB) - ) Cyclizine - H1 (+++), ACh (+), PO/SC/IV
- acts on H1 receptors in the vomiting centre and the CNVIII nucleus as well as vagally-mediated N+V
- mechanical bowel obstruction: vagally mediated
- raised ICP/intracerebral: CN VIII affected in raised ICP
- movement disorders: CN VIII
- used 2nd line for post-op N+V (unable to use ondansetron)
- dose: PO 50mg BD-TDS, syringe driver in obstruction
- side effects: drowsiness and anti-muscarinic SEs - ) Ondansetron - 5HT3 (+++), PO/IV
- prevents serotonin exciting enteric neurones which ↓GI motility/peristalsis and ↓GI secretions
- usage: post-op, chemo/radiotherapy-induced N+V
- side effects: constipation, headache, ↑LFTs, QT prolongation, extra-pyramidal effects
- avoid in migraines as triptans use HT3 receptors - ) Levomepromazine - 5HT2 (+++), (D2+, ACh+, H1+)
- can be used orally or SC as an infusion
- best used in end of life care as it is sedating - ) Dexamethasone - reduces inflammation/swelling
- mainly oral but can also be given in a SC infusion
- used alongside cyclizine for raised ICP N+V as well as N+V due to bowel obstruction
- can affect circadian rhythm so avoid past 6pm
Constipation
Causes
Clinical Features
Management
- ) Causes
- drugs: opioids, antimuscarinics, antacids
- secondary effects of disease: dehydration, inactivity, ↓fibre, delirium, MSCC, lack of privacy
- direct effects of malignant tumours: nerve damage, bowel obstruction, hypercalcaemia - ) Clinical Features
- unsatisfactory defecation due to infrequent stools, difficult stool passage or tenesmus
- stools are often dry and hard, may be abnormal size
- associated sx: abdominal pain and distension, N+V, flatulence, overflow diarrhoea, anorexia, malaise, and distress or worsening confusion
- must exclude: faecal impaction, bowel obstruction, anal fissures, painful haemorrhoids, local tumours - ) Management
- alleviate contributing factors: impaction, poor diet, dehydration, having to use a bedpan, lack of privacy, anal fissure, painful haemorrhoids, or local tumour
- prevention: stimulant laxative (Senna) should be prescribed alongside constipating agents (opioids)
- 1°: stimulant laxative e.g. Senna
- 2°: add an osmotic (Macrogol/Lactulose) OR stool softener (docusate sodium)
- 3°: rectal treatment via suppository or enema
Malignant Bowel Obstruction
Pathophysiology
Operable Bowel Obstruction
Inoperable Bowel Obstruction
- ) Pathophysiology - often a gradual onset and a combination of mechanical and functional obstruction
- mechanical: tumour w/in lumen or outside bowel wall
- functional: infiltration of myenteric plexus
- more common in bowel and ovarian cancer - ) Operable Bowel Obstruction
- surgical intervention: has high morbidity/mortality
- endoscopic stenting, venting gastrostomy
- cautious use of pro-kinetic may help partial or functional obstruction - ) Inoperable Bowel Obstruction
- rest bowel initially to see if it will resolve: limit oral fluids, give IV hydration, NG tube for large vomiting
- correct electrolyte imbalances (↓K, ↓Mg)
- analgesics, anti-emetics, anti-secretory drugs (octreotide - somatostatin analogue)
- hyoscine butylbromide can be used for bowel colic caused by bowel obstruction
- trial of dexamethasone
- not resolving: syringe driver, prognosis will be weeks to months
Intractable Breathlessness
Pathophysiology
General Management
Medical Management
- ) Pathophysiology - breathlessness is an objective sign, whereas dyspnoea is a subjective symptom
- direct causes: primary lung cancer or lung mets
- indirect effects of cancer: anaemia, pleural effusion, PE, SVCO, surgery
- non-malignant causes: pneumonia, COPD, heart failure, and anxiety (major part of dyspnoea) - ) General Management
- simple measures: relaxation and breathing techniques, keep the room cool (fan, open window)
- encourage exercise within the person’s capabilities
- adaptations of ADLs and lifestyle expectations - ) Medical Management - these can be considered
- low dose IR morphine e.g. oramorph 1-2mg PRN
- short term benzo: SL lorazepam or SC midazolam
- bronchodilator if wheeze is thought to be caused by partial airway obstruction from a tumour
- oxygen therapy: if at risk of symptomatic hypoxia
Signs of Impending Death
Cardiac and Circulatory Changes
Respiratory Changes
GI/GU Changes
General Changes
- ) Cardiac and Circulatory Changes
- skin mottling/discolouration: ↓blood perfusion
- ↓consciousness/delirium: ↓cerebral perfusion
- ↓CO: ↓ BP, ↑HR, central/peripheral cyanosis - ) Respiratory Changes
- noisy respirations: due to retention of secretions in the pharynx and the upper respiratory tract
- Cheyne-Stokes respirations: notable changes in breathing, reassure families that this is normal - ) GI/GU Changes
- ↓appetite: weight loss, dehydration, do not need to force food or fluids, provide good mouth care
- swallowing difficulties: stop feeding if choking
- ↓urine output: may have urinary incontinence - ) General Changes
- prolonged drowsiness, sleeping more due to profound weakness and fatigue, this is normal
- become more withdrawn and detached from surroundings due to disorientation
- hallucinations: may see or speak to things, normal
- pressure ulcers from being bedbound
Anticipatory Medicines for End of Life Care
General Information Pain and/or Breathlessness Anxiety, Agitation, and Seizures Nausea+Vomiting, Hallucinations Respiratory Secretions
General Information
- involve patients and relatives in discussions early
- stop any medications that have no benefit
- switch essential medications to non-oral routes
- most drugs given through a syringe driver
- always use the lowest effective dose
- ) Pain and/or Breathlessness
- SC infusion of morphine for regular pain
- SC PRN (1hrly) morphine 2.5-5mg 1hrly - ) Anxiety, Agitation, and Seizures
- SC PRN (1hrly) midazolam 2.5-5mg
- can give SC infusion of an anti-epileptic if suffering from seizures already - ) Nausea+Vomiting, Hallucinations
- SC PRN (4hrly) Levomepromazine 2.5-5mg - ) Respiratory Secretions
- SC PRN (4hrly) glycopyyronium 200-400mcg
- can be aided by sitting the patient up
- alternative is hyoscine butylbromide (hyoscine hydrobromide causes sedative effects)
- hyoscine butylbromide is also used in bowel colic which may occur from bowel obstruction
Intractable Hiccups - 1°chlorpromazine OR haloperidol, gabapentin, dexamethasone is also used particularly if there are hepatic lesions